Company profile
Seaport Therapeutics, Inc. Insider Trading
SPTXEvery SEC Form 4 insider trading filing for Seaport Therapeutics, Inc. (SPTX) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0002042347
- Filings
- 15
- Insiders
- 21
- Last filing
- 2026-06-22
Activity summary
No insider transactions in the last 30 days. The most recent was on June 22, 2026, when Robert J. Hombach bought 13,000 shares. 15 filings from 21 insiders are on record below.
No insider activity recorded for SPTX in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Robert J. Hombach | SPTX | Purchase | 13,000 | $18.14 | $236K |
| May 4, 2026 | PureTech Health plc | SPTX | C | 12,736,014 | — | — |
| May 4, 2026 | PureTech Health plc | SPTX | C | 2,681,265 | — | — |
| May 4, 2026 | PureTech Health plc | SPTX | C | 965,255 | — | — |
| May 4, 2026 | PureTech Health plc | SPTX | C | 40,000,000 | — | — |
36 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=SPTX" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.